RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Mercy BioAnalytics

Mercy BioAnalytics

Mercy BioAnalytics is a biotechnology company that aims to improve and save the lives of people through the early detection of cancer.

Latest funding

$59M Series B+ ·

Led by Novalis LifeSciences · Source: fundraisingfox.com

Total raised: $100M across 2 sourced rounds

All 2 rounds ↓
Website: mercybio.com.
LinkedIn: linkedin.com.
Sectors: Biotechnology, Health Care, Life Science, Therapeutics.
Stage: Series B+.
Based in: Waltham, United States.
Total raised: $100M in 2 sourced rounds.
Last round: Sep 3, 2025 · 439 days ago.
Headcount: 11–50 employees.
On Recent Funding since: Oct 1, 2026.

Signals

Website registeredMar 11, 2018 (8 years old)

Funding rounds

DateRoundAmountLeadSource
Series B+$59MNNovalis LifeSciencesfundraisingfox.com
Series A$41MNNovalis LifeSciencesfundraisingfox.com

Timeline

  1. Website created

Founders and team

Investors

Companies like Mercy BioAnalytics

Other companies backed by Novalis LifeSciences

Novalis LifeSciences portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/mercy-bioanalytics (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy